48 related articles for article (PubMed ID: 15820970)
1. Castration reduces platelet thromboxane A2 receptor density and aggregability.
Ajayi AA; Halushka PV
QJM; 2005 May; 98(5):349-56. PubMed ID: 15820970
[TBL] [Abstract][Full Text] [Related]
2. Difluorinated thromboxane A
Allen MF; Hutchinson JL; Keith M; Mallah S; Corey RA; Trory JS; Jing C; Fang H; Wei L; Bennett SH; Aggarwal VK; Mundell SJ; Hers I
Br J Pharmacol; 2024 Jun; ():. PubMed ID: 38840293
[TBL] [Abstract][Full Text] [Related]
3. Flavonoids inhibit platelet function through binding to the thromboxane A2 receptor.
Guerrero JA; Lozano ML; Castillo J; Benavente-García O; Vicente V; Rivera J
J Thromb Haemost; 2005 Feb; 3(2):369-76. PubMed ID: 15670046
[TBL] [Abstract][Full Text] [Related]
4. Hormones, age, and sex affect platelet responsiveness in vitro.
Hadley JB; Kelher MR; Coleman JR; Kelly KK; Dumont LJ; Esparza O; Banerjee A; Cohen MJ; Jones K; Silliman CC
Transfusion; 2022 Sep; 62(9):1882-1893. PubMed ID: 35929193
[TBL] [Abstract][Full Text] [Related]
5. The role of the androgen receptor in prostate cancer-induced platelet aggregation and platelet-induced invasion.
Rudzinski JK; Govindasamy NP; Lewis JD; Jurasz P
J Thromb Haemost; 2020 Nov; 18(11):2976-2986. PubMed ID: 32692888
[TBL] [Abstract][Full Text] [Related]
6. TxA
Ahmad F
J Am Heart Assoc; 2018 Jun; 7(13):. PubMed ID: 29936415
[No Abstract] [Full Text] [Related]
7. Glucagon-Like Peptide-1 Receptor Regulates Thromboxane-Induced Human Platelet Activation.
Cahill KN; Amin T; Boutaud O; Printz R; Newcomb DC; Foer D; Hodson DJ; Broichhagen J; Beckman JA; Yu C; Nian H; Mashayekhi M; Silver HJ; Luther JM; Brown NJ; Peebles RS; Niswender K
JACC Basic Transl Sci; 2022 Jul; 7(7):713-715. PubMed ID: 35958685
[No Abstract] [Full Text] [Related]
8. Testosterone increases human platelet thromboxane A2 receptor density and aggregation responses.
Ajayi AA; Mathur R; Halushka PV
Circulation; 1995 Jun; 91(11):2742-7. PubMed ID: 7758179
[TBL] [Abstract][Full Text] [Related]
9. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline.
Bhasin S; Brito JP; Cunningham GR; Hayes FJ; Hodis HN; Matsumoto AM; Snyder PJ; Swerdloff RS; Wu FC; Yialamas MA
J Clin Endocrinol Metab; 2018 May; 103(5):1715-1744. PubMed ID: 29562364
[TBL] [Abstract][Full Text] [Related]
10. Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels.
Vigen R; O'Donnell CI; Barón AE; Grunwald GK; Maddox TM; Bradley SM; Barqawi A; Woning G; Wierman ME; Plomondon ME; Rumsfeld JS; Ho PM
JAMA; 2013 Nov; 310(17):1829-36. PubMed ID: 24193080
[TBL] [Abstract][Full Text] [Related]
11. The Effect of Testosterone on Cardiovascular Disease and Cardiovascular Risk Factors in Men: A Review of Clinical and Preclinical Data.
Kaur H; Werstuck GH
CJC Open; 2021 Oct; 3(10):1238-1248. PubMed ID: 34888506
[TBL] [Abstract][Full Text] [Related]
12. Effect of Berberine on Cardiovascular Disease Risk Factors: A Mechanistic Randomized Controlled Trial.
Zhao JV; Yeung WF; Chan YH; Vackova D; Leung JYY; Ip DKM; Zhao J; Ho WK; Tse HF; Schooling CM
Nutrients; 2021 Jul; 13(8):. PubMed ID: 34444711
[TBL] [Abstract][Full Text] [Related]
13. Investigating the association of testosterone with survival in men and women using a Mendelian randomization study in the UK Biobank.
Schooling CM; Zhao JV
Sci Rep; 2021 Jul; 11(1):14039. PubMed ID: 34234209
[TBL] [Abstract][Full Text] [Related]
14. Effects of Exogenous Androgens on Platelet Activity and Their Thrombogenic Potential in Supraphysiological Administration: A Literature Review.
Roşca AE; Vlădăreanu AM; Mititelu A; Popescu BO; Badiu C; Căruntu C; Voiculescu SE; Onisâi M; Gologan Ş; Mirica R; Zăgrean L
J Clin Med; 2021 Jan; 10(1):. PubMed ID: 33406783
[TBL] [Abstract][Full Text] [Related]
15. Investigating pleiotropic effects of statins on ischemic heart disease in the UK Biobank using Mendelian randomisation.
Schooling CM; Zhao JV; Au Yeung SL; Leung GM
Elife; 2020 Aug; 9():. PubMed ID: 32838838
[TBL] [Abstract][Full Text] [Related]
16. Platelet Responses in Cardiovascular Disease: Sex-Related Differences in Nutritional and Pharmacological Interventions.
Gasperi V; Catani MV; Savini I
Cardiovasc Ther; 2020; 2020():2342837. PubMed ID: 32547635
[TBL] [Abstract][Full Text] [Related]
17. Testosterone replacement therapy and cardiovascular risk.
Gagliano-Jucá T; Basaria S
Nat Rev Cardiol; 2019 Sep; 16(9):555-574. PubMed ID: 31123340
[TBL] [Abstract][Full Text] [Related]
18. Association of genetically predicted testosterone with thromboembolism, heart failure, and myocardial infarction: mendelian randomisation study in UK Biobank.
Luo S; Au Yeung SL; Zhao JV; Burgess S; Schooling CM
BMJ; 2019 Mar; 364():l476. PubMed ID: 30842065
[TBL] [Abstract][Full Text] [Related]
19. Trials of testosterone replacement reporting cardiovascular adverse events.
Gagliano-Jucá T; Basaria S
Asian J Androl; 2018; 20(2):131-137. PubMed ID: 28782738
[TBL] [Abstract][Full Text] [Related]
20. Could androgens be relevant to partly explain why men have lower life expectancy than women?
Schooling CM
J Epidemiol Community Health; 2016 Apr; 70(4):324-8. PubMed ID: 26659456
[No Abstract] [Full Text] [Related]
[Next] [New Search]
